Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 14


Evidence-Based Treatments for Adults with Migraine.

Gooriah R, Nimeri R, Ahmed F.

Pain Res Treat. 2015;2015:629382. doi: 10.1155/2015/629382. Epub 2015 Dec 29. Review.


A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.

Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A, Sehgal N, Kuester J.

PLoS One. 2015 Jul 14;10(7):e0130733. doi: 10.1371/journal.pone.0130733. eCollection 2015.


The diagnosis and treatment of chronic migraine.

Weatherall MW.

Ther Adv Chronic Dis. 2015 May;6(3):115-23. doi: 10.1177/2040622315579627. Review.


Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.

Gaul C, Diener HC, Danesch U; Migravent® Study Group.

J Headache Pain. 2015;16:516. doi: 10.1186/s10194-015-0516-6. Epub 2015 Apr 3.


Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura.

Pietrini U, De Luca M, Del Bene E, De Cesaris F, Bertinotti L, Colangelo N, Moggi Pignone A.

Curr Ther Res Clin Exp. 2004 Jan;65(1):70-8. doi: 10.1016/S0011-393X(04)90006-9.


The acute and preventative treatment of episodic migraine.

Miller S.

Ann Indian Acad Neurol. 2012 Aug;15(Suppl 1):S33-9.


Patient outcome in migraine prophylaxis: the role of psychopharmacological agents.

Pompili M, Serafini G, Innamorati M, Serra G, Dominici G, Fortes-Lindau J, Pastina M, Telesforo L, Lester D, Girardi P, Tatarelli R, Martelletti P.

Patient Relat Outcome Meas. 2010 Jul;1:107-18. doi: 10.2147/PROM.S9742. Epub 2010 Sep 17.


Italian guidelines for primary headaches: 2012 revised version.

Sarchielli P, Granella F, Prudenzano MP, Pini LA, Guidetti V, Bono G, Pinessi L, Alessandri M, Antonaci F, Fanciullacci M, Ferrari A, Guazzelli M, Nappi G, Sances G, Sandrini G, Savi L, Tassorelli C, Zanchin G.

J Headache Pain. 2012 May;13 Suppl 2:S31-70. doi: 10.1007/s10194-012-0437-6.


Are the current IHS guidelines for migraine drug trials being followed?

Hougaard A, Tfelt-Hansen P.

J Headache Pain. 2010 Dec;11(6):457-68. doi: 10.1007/s10194-010-0257-5. Epub 2010 Oct 8. Review.


Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L.

BMJ. 2010 Sep 29;341:c4871. doi: 10.1136/bmj.c4871.


Prevention of episodic migraines with topiramate: results from a non-interventional study in a general practice setting.

Nelles G, Schmitt L, Humbert T, Becker V, Sandow P, Bornhoevd K, Fritzsche D, Schäuble B; TOPMATMIG-0001 investigators.

J Headache Pain. 2010 Feb;11(1):33-44. doi: 10.1007/s10194-009-0163-x. Epub 2009 Nov 6.


Is placebo acupuncture what it is intended to be?

Lundeberg T, Lund I, Sing A, Näslund J.

Evid Based Complement Alternat Med. 2011;2011:932407. doi: 10.1093/ecam/nep049. Epub 2011 Jun 18.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk